New light therapy combo aims to soothe dry eyes

NCT ID NCT07239128

Completed Disease control Sponsor: University of Seville Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether low-level light therapy (LLLT) plus non-steroidal immunosuppressant eye drops can help people with dry eye disease. 160 participants received three weekly light sessions along with either cyclosporine or tacrolimus drops. The goal was to see if the combination improves symptoms and tear film stability better than drops alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Low-level light therapy (LLLT) and topical cyclosporine A or tacrolimus
What this could lead to: If successful, this combination could offer a new, non-invasive way to manage dry eye symptoms and improve eye comfort.
What could go wrong: This is a very early (Phase 1) study with no results yet. The benefits may be small or not better than existing treatments, and light therapy devices are not widely available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY EYE DISEASE (DED)

Contacts and locations

Locations

Biomeeting Day Surgery center

Reggio Calabria, Calabria, 89123, Italy
Centro Oculistico Borroni

Gallarate, Varese, 21013, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.